iSpecimen Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- iSpecimen Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $2.50M.
- iSpecimen Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $1.36M.
- iSpecimen Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $138.49K.
- iSpecimen Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $2.50M.
- iSpecimen Inc. stock issued during period, value, new issues for fiscal 2024 was $398.44K.
- iSpecimen Inc. stock issued during period, value, new issues for fiscal 2021 was $18.00M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $2.50M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $398.44K 10-K · filed 2026-04-01 | |
| 2024-06-30 | $1.36M 10-Q · filed 2024-11-07 | |
| 2024-03-31 | $138.49K 10-Q · filed 2025-05-19 | |
| 2021-12-31 | $18.00M 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | $2.50M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $18.00M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |